Results 151 to 160 of about 10,135 (204)

Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases. [PDF]

Front Immunol
Ma T, Zhu Y, Zhu R.
europepmc   +1 more source

Effectiveness of Immunosuppressive Therapy in Preventing the Progression of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Nall S, Majeed J, Ahmed Mohsen Alrashidi A, Alhneif M, Hannan Asghar A, Mubarik A, Ahmed Mohsen Alrashidi I, Allahwala D.   +7 more
europepmc   +1 more source

New-onset ocular myasthenia gravis following SARS-CoV-2 infection.

Oman J Ophthalmol, 2023
Banerjee P, Hassan H, Alam MS.
europepmc   +1 more source

Juvenile ocular myasthenia gravis: a report of two cases. [PDF]

Digit J Ophthalmol
Gabbard R, Yi R, Pratt J, Chang K, Keck K.   +4 more
europepmc   +1 more source

Ocular Myasthenia Gravis As Unilateral Ptosis and External Ophthalmoplegia: A Case Report. [PDF]

Cureus
Tanveer S, Tahir A, Ahmad O, Bibi K, Khan S.   +4 more
europepmc   +1 more source

Efgartigimod-associated Kaposi's varicelliform eruption and herpetic conjunctivitis in a patient with seropositive ocular myasthenia gravis: a case report and review. [PDF]

Front Immunol
Ge L, Li Y, Sun Y, Chen W, Ni X, Wei F, Mu Z.   +6 more
europepmc   +1 more source

Prevalences of Other Non-Thyroid Autoimmune Diseases and Factor Associated with Their Presence in Ocular Myasthenia Gravis. [PDF]

Clin Ophthalmol
Anutraungkool T, Padungkiatsagul T, Jindahra P, Vanikieti K.   +3 more
europepmc   +1 more source

A Male Patient Presents With Isolated Abducens Nerve Palsy: An Atypical Presentation of Ocular Myasthenia Gravis. [PDF]

Cureus
Sanchez JC, Belmar MT, Sanchez J, Mercen JL, Prieto J.   +4 more
europepmc   +1 more source

An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts [PDF]

core   +1 more source

A controlled clinical study on efficacy and safety of periocular triamcinolone acetonide injection for treating ocular myasthenia gravis. [PDF]

BMC Ophthalmol
Shi M, Lu Z, Qin A, Cheng J, Chen S, Xing Y.   +5 more
europepmc   +1 more source